Your browser doesn't support javascript.
loading
Mechanistic modeling of SARS-CoV-2 immune memory, variants, and vaccines
Jamie A Cohen; Robyn Margaret Stuart; Katherine Rosenfeld; Hil Lyons; Michael White; Cliff Kerr; Daniel J Klein; Michael Famulare.
Affiliation
  • Jamie A Cohen; Institute for Disease Modeling
  • Robyn Margaret Stuart; University of Copenhagen
  • Katherine Rosenfeld; Institute for Disease Modeling
  • Hil Lyons; Institute for Disease Modeling
  • Michael White; Institut Pasteur
  • Cliff Kerr; Institute for Disease Modeling
  • Daniel J Klein; Institute for Disease Modeling
  • Michael Famulare; Institute for Disease Modeling
Preprint in English | medRxiv | ID: ppmedrxiv-21258018
ABSTRACT
The functional relationship between neutralizing antibodies (NAbs) and protection against SARS-CoV-2 infection and disease remains unclear. We jointly estimated protection against infection and disease progression following natural infection and vaccination from meta-study data. We find that NAbs are strongly correlated with prevention of infection and that any history of NAbs will stimulate immune memory to moderate disease progression. We also find that natural infection provides stronger protection than vaccination for the same level of NAbs, noting that infection itself, unlike vaccination, carries risk of morbidity and mortality, and that our most potent vaccines induce much higher NAb levels than natural infection. These results suggest that while sterilizing immunity may decay, we expect protection against severe disease to be robust over time and in the face of immune-evading variants.
License
cc_by
Full text: Available Collection: Preprints Database: medRxiv Type of study: Prognostic study Language: English Year: 2021 Document type: Preprint
Full text: Available Collection: Preprints Database: medRxiv Type of study: Prognostic study Language: English Year: 2021 Document type: Preprint
...